Advertisement Pharmaceutical Business review - Page 435 of 5255 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
December 23, 2025

Samsung Biologics to acquire Human Genome Sciences

Samsung Biologics has entered into a definitive agreement, through its subsidiary Samsung Biologics America, to acquire Human Genome Sciences from GSK as part of its plan to expand manufacturing capabilities in the US.

Continue
The Rockville, Maryland facility has two cGMP plants in a key US bio-cluster, with 60,000 litres capacity. Credit: Samsung Biologics/PRNewswire.
December 23, 2025

Genentech secures FDA approval for Lunsumio VELO SC for follicular lymphoma

The study showed a 75% objective response rate, 59% complete response rate, and 22.4 months median response duration. Credit: Gorodenkoff/Shutterstock.com.
December 22, 2025

Cytokinetics receives FDA approval for MYQORZO tablets for oHCM

In patients suffering with oHCM, myosin inhibition with MYQORZO lowers left ventricular outflow tract obstruction and cardiac contractility. Credit: NMK-Studio/Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. MEDIPOST, Teikoku Seiyaku partner for CARTISTEM commercialisation in Japan
  2. MHRA launches call for evidence on AI regulation in UK healthcare sector
  3. J&J receives FDA approval for lung cancer therapy
  4. EC approves Incyte’s Minjuvi combo for follicular lymphoma
  5. Alnylam plans $250m investment in Norton manufacturing facility, US

PRESS RELEASES

SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Pharmaceutical Business Review
Christian Mias to Succeed Andreas Reisse as CEO of SCHOTT Pharma
Pharmaceutical Business Review
LTS completes acquisition of Renaissance Lakewood, expanding global CDMO capabilities

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography